-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Telomir Pharmaceuticals, Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
- Telomir Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $863,132, a 55% increase year-over-year.
- Telomir Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $5,070,428, a 31% decline from 2023.
- Telomir Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $3,859,796, a 724% decline from 2022.